idazoxan has been researched along with Amentia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenup, JL; Leverenz, JB; Peskind, ER; Raskind, MA; Szot, P; White, SS | 1 |
| Coull, JJ; Hodges, JR; Sahakian, BJ | 1 |
| Coull, JT; Hodges, JR; Sahakian, BJ | 1 |
| Conway, SC; Ebmeier, KP; Glabus, MF; Goodwin, GM; O'Carroll, RE; Peyro-Saint-Paul, H | 1 |
| Robles Bayón, A | 1 |
| Ghika, J; Growdon, J; Hoffman, E; Schoenfeld, D; Tennis, M | 1 |
3 trial(s) available for idazoxan and Amentia
| Article | Year |
|---|---|
The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.
Topics: Adrenergic alpha-Antagonists; Aged; Attention; Cognition; Dementia; Female; Frontal Lobe; Humans; Idazoxan; Male; Middle Aged | 1996 |
Executive function and uptake of 99mTc-exametazime shown by single photon emission tomography after oral idazoxan in probable Alzheimer-type dementia.
Topics: Adrenergic alpha-Antagonists; Aged; Brain; Cognition; Dementia; Female; Humans; Idazoxan; Male; Neuropsychological Tests; Perfusion; Tomography, Emission-Computed, Single-Photon | 1997 |
Idazoxan treatment in progressive supranuclear palsy.
Topics: Adrenergic alpha-Antagonists; Aged; Dementia; Depression; Dioxanes; Female; Gait; Humans; Idazoxan; Male; Movement; Severity of Illness Index; Supranuclear Palsy, Progressive | 1991 |
3 other study(ies) available for idazoxan and Amentia
| Article | Year |
|---|---|
Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Dementia; Female; Gene Expression Regulation; Humans; Idazoxan; Male; Middle Aged; Postmortem Changes; Prazosin; Prefrontal Cortex; Receptors, Adrenergic; RNA, Messenger | 2007 |
Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type.
Topics: Administration, Oral; Cognition; Dementia; Dioxanes; Double-Blind Method; Frontal Lobe; Humans; Idazoxan; Male; Placebos; Receptors, Adrenergic, alpha; Treatment Outcome; Verbal Behavior | 1994 |
[Frontotemporal dementia: therapeutic possibilities].
Topics: Adrenergic alpha-Antagonists; Dementia; Frontal Lobe; Humans; Idazoxan; Primary Health Care; Temporal Lobe | 2000 |